ASU researchers use environmental factors to predict valley fever spreadContinue reading
Category Archives: AZBio News
New 3D technology paves way for next-generation eye tracking
Eye tracking plays a critical role in the latest virtual and augmented reality headsets and is an important technology in the entertainment industry, scientific research, medical and behavioral sciences, automotive driving assistance and industrial engineering. Tracking the movements of the human eye with high accuracy, however, is a daunting challenge.Continue reading
ABOR Confirms the Appointment of Janko Nikolich as a Regents Professor
Regents Professor is the highest faculty rank at the University of Arizona, awarded to full professors whose exceptional achievements warrant national and international distinction. Appointments to this rank are limited to no more than 3% of the university’s tenured and tenure-track faculty members.Continue reading
Picard Medical Plans IPO on the NYSE
Picard Medical, Inc. is a holding company that owns 100% of the membership interests of SynCardia Systems, LLC (“SynCardia”). A medical technology company based in Tucson, AZ, SynCardia manufactures and sells the only U.S. Food and Drug Administration (“FDA”), and Health Canada approved implantable total artificial heart (the “SynCardia TAH”). To date, over 2,100 SynCardia TAHs have been implanted in patients in 27 countries and the SynCardia TAH is an established bridge to heart transplantation for patients with biventricular failure in the U.S., and around the world.
BIRD Foundation Call for Proposals – May 14 2025 Deadline
The BIRD Foundation was established by the U.S. and Israeli governments in 1977 to generate mutually beneficial cooperation between U.S. and Israeli companies, including start-ups and established organizations. BIRD provides both matchmaking support between U.S. and Israeli companies, as well as funding covering up to 50 percent of project development costs, up to $1.5M per project. BIRD takes no equity in the companies.Continue reading
C-Path’s Predictive Safety Testing Consortium Advances a Transformative Test to Detect Drug Induced Liver Injury
Serum Glutamate Dehydrogenase Activity Enables Sensitive and Specific Diagnosis of Hepatocellular Injury in HumansContinue reading
ALL ALS consortium launches website to advance ALS research
Newly established clinical research consortium, led by Barrow Neurological Institute and Massachusetts General Hospital, surpasses 300 study participants
C-Path Announces Paul E. Edmeier as New Chief Financial Officer
New CFO to Lead Financial Strategy and Global Compliance at C-PathContinue reading
C-Path Announces Successful Conclusion of the eCOA: Getting Better Together Initiative
Collaboration has culminated in meaningful, lasting changes for the benefit of stakeholders in the electronic collection of clinical outcome assessment data in clinical trialsContinue reading
HHS Announces Restructure and Staff Reductions
“The restructuring will address this and serve multiple goals without impacting critical services. First, it will save taxpayers $1.8 billion per year through a reduction in workforce of about 10,000 full-time employees who are part of this most recent transformation. When combined with HHS’ other efforts, including early retirement and Fork in the Road, the restructuring results in a total downsizing from 82,000 to 62,000 full-time employees.”Continue reading